SEC 8-K filings, classified by Claude with reasoning. Updated nightly from EDGAR's daily index (~10 PM ET).
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The disclosure centers on shareholder approval of the 2026 Stock Incentive Plan, which replaces the prior 2016 plan and authorizes the Compensation Committee to grant stock options, restricted stock, restricted stock units, and performance awards to eligible employees. This is a compensatory arrangement disclosure under Item 5.02(e), material because it establishes the framework for executive and employee equity compensation going forward.
View raw filing on EDGAR →The disclosure centers on shareholder approval of the Amended and Restated 2023 Omnibus Equity Incentive Plan, which is a compensatory arrangement for officers and directors. The filing details the plan's material terms, including an increase of 1,500,000 shares available for equity-based awards and an extension of the termination date to 2036. This is a classic Item 5.02(e) disclosure of a compensation plan amendment approved by shareholders.
View raw filing on EDGAR →The filing discloses amendments to employment agreements for Michael Winston (Executive Chairman and Interim CEO) and George Murnane (Interim CFO) that materially modify their compensatory arrangements and restrictive covenants. The amendments extend non-compete and non-solicitation periods from one to two years, introduce a new clawback provision for incentive-based compensation and bonuses, and provide $1,000 one-time bonuses in exchange for covenant compliance. These modifications to executive compensation terms and incentive structures are the principal disclosed action, making this an exec_compensation event rather than a departure or appointment.
View raw filing on EDGAR →The disclosure centers on stockholder approval of an amendment to the 2018 Equity Incentive Plan increasing authorized shares by 3,000,000 shares. This is a compensatory arrangement disclosure under Item 5.02(e), as it involves approval of a material equity plan amendment that affects the pool of shares available for executive and employee compensation grants. While shareholder vote results are also mentioned, the substantive focus is on the equity plan amendment itself.
View raw filing on EDGAR →The disclosure reports stockholder approval of an amendment to the 2023 Long-Term Incentive Plan increasing authorized shares by 3,260,000 shares. This is a compensatory arrangement affecting equity grants and incentive compensation for officers and directors, fitting the exec_compensation category. The material increase in share authorization and shareholder approval make this material to investors assessing dilution and executive compensation capacity.
View raw filing on EDGAR →The disclosure reports stockholder approval of amendments to the MaxLinear Amended and Restated 2010 Equity Incentive Plan and 2010 Employee Stock Purchase Plan, including a new ten-year term, an increase of 3,204,107 shares reserved, and removal of automatic share increases. These are compensatory arrangements affecting equity grants and employee stock purchase eligibility, fitting the exec_compensation category. The materiality is high given the substantial share reserve increase and plan restructuring affecting future executive and employee compensation.
View raw filing on EDGAR →This disclosure reports shareholder approval of the Kohl's Corporation 2024 Long-Term Compensation Plan, as amended and restated effective May 20, 2026. The filing explicitly states "The Plan is a material compensatory arrangement in which the Company's named executive officers are eligible to participate" and details material amendments including a 5.2 million share authorization increase, a ten-year plan extension through 2036, and a $750,000 annual compensation cap for non-employee directors. This is a classic exec_compensation event involving shareholder approval of a compensatory plan arrangement.
View raw filing on EDGAR →While the section discloses both an executive departure (William R. Devlin retiring as Chief Accounting Officer effective June 1, 2026) and an appointment (Samuel M. Guzman Jr. becoming Senior Vice President, Chief Accounting Officer and Controller), the bulk of the Item 5.02 disclosure centers on Item 5.02(e) compensatory arrangements. The Compensation Committee approved three incentive compensation programs (Eagle Plan, Business Unit Plan, and Special Situation Program) with specific bonus pools, performance metrics, and maximum bonus potentials for named executive officers. The compensation disclosure is more extensive and material than the succession narrative, making exec_compensation the most salient classification.
View raw filing on EDGAR →The disclosure centers on shareholder approval of an amended and restated omnibus incentive plan that increases share reserves by 375,000 shares, adds vesting requirements, and modifies equity award terms. This is a compensatory arrangement disclosure under Item 5.02(e), affecting the framework for director and officer equity compensation. The material increase in authorized shares and modification of plan terms would affect investor assessment of dilution and executive incentive structures.
View raw filing on EDGAR →The filing's primary disclosure is stockholder approval of the "Seventh Amended and Restated 2013 Incentive Compensation Plan," which is a material compensatory arrangement affecting equity grants and performance awards for officers and directors. While the section also includes routine committee appointments and board composition changes, the substantive Item 5.02(e) event centers on the Plan adoption, making exec_compensation the most salient classification.
View raw filing on EDGAR →The disclosure reports shareholder approval of an amendment and restatement of the Company's Employee Stock Purchase Plan (ESPP), which increases authorized shares from 100,000 to 400,000 (a 300,000 share increase). This is a compensatory arrangement affecting employees and is material to investors as it expands equity dilution and employee compensation capacity. The event centers on a compensation plan amendment approved at the annual meeting, fitting the exec_compensation category.
View raw filing on EDGAR →The disclosure centers on equity compensation awards granted to Brent Pfeiffenberger in connection with his Board appointment: a nonqualified stock option for 24,700 shares and a restricted stock unit award for 7,500 shares, both vesting over three years. While the section mentions his appointment, the substantive disclosure focuses on the compensatory arrangements themselves, making this an exec_compensation event rather than exec_appointment.
View raw filing on EDGAR →The primary disclosure centers on an Amended and Restated Change in Control Agreement with Mark J. Parrell that modifies his severance formula to 2.25x base salary plus target bonus and equity grant, plus 27 months of benefits continuation. This is a material modification to compensatory arrangements for a named executive officer. While the section also mentions an offer letter for Benjamin W. Schall as incoming CEO, the substantive compensation disclosure focuses on Parrell's amended severance terms.
View raw filing on EDGAR →The disclosure centers on shareholder approval of the Aebi Schmidt Equity Incentive Plan, which authorizes the Board to grant restricted share units, performance share units, and restricted shares to executives, employees, and non-executive Board members. This is a compensatory arrangement disclosure under Item 5.02(e), establishing a material equity compensation framework with 3.5 million shares authorized and performance-based incentive provisions.
View raw filing on EDGAR →The disclosure centers on the Board's approval of a new Change in Control Employment Agreement with Vincent P. Berger II, the Executive Vice President and Chief Financial Officer, effective June 1, 2026. The filing details severance benefits, eligibility triggers, and compensation arrangements in the event of a change in control and termination. This is a compensatory arrangement for a named executive officer, replacing a prior agreement that expires on the same date, and would materially affect investor assessment of executive protections and potential costs in a change-of-control scenario.
View raw filing on EDGAR →The disclosure reports stockholder approval of an amendment to the Citigroup 2019 Stock Incentive Plan that increases authorized shares available for grant by 20 million shares. This is a compensatory arrangement amendment affecting equity incentive capacity for officers and directors, fitting the exec_compensation category. The material increase in share authorization would affect investor assessment of dilution and executive compensation capacity.
View raw filing on EDGAR →The disclosure reports stockholder approval of the First Amendment to the 2023 Omnibus Incentive Plan, increasing reserved shares by 35 million shares to support equity awards. This is a compensatory arrangement amendment affecting the pool of shares available for executive and employee equity grants, which is a core exec_compensation event under Item 5.02(e). The material increase in share authorization and stockholder approval make this material to investors assessing dilution and compensation practices.
View raw filing on EDGAR →The disclosure centers on stockholder approval and adoption of the 2026 Incentive Plan, a compensatory arrangement that governs equity grants, performance awards, and cash-based awards for employees, officers, directors, and consultants. The plan reserves 3.5 million shares and establishes the framework for executive and employee compensation, making this a material executive compensation disclosure under Item 5.02(e).
View raw filing on EDGAR →The filing discloses an award of restricted stock units (RSUs) to non-employee directors on May 21, 2026, with the award agreement filed as an exhibit. This constitutes a compensatory arrangement for directors and falls squarely within exec_compensation, which covers equity grants to named executives and directors. While disclosed under Item 8.01 (Other Events) rather than the typical Item 5.02(e), the substance is a material equity compensation grant.
View raw filing on EDGAR →The disclosure centers on stockholder approval of the 2026 Equity Incentive Plan on May 20, 2026, which authorizes the issuance of up to 12,000,000 new shares plus additional shares from the Prior Plan for equity-based awards to employees, directors, consultants and advisors. This is a compensatory arrangement disclosure under Item 5.02(e), distinct from executive departures or appointments. The plan's authorization of substantial equity issuance and adoption of RSU and PSU award agreement forms constitute material compensation governance changes.
View raw filing on EDGAR →The filing discloses stockholder approval of an Amended and Restated 2022 Stock Incentive Plan at the Annual Meeting on May 21, 2026. This is a compensatory arrangement affecting directors and officers, falling squarely within the exec_compensation category. The amendment to a stock incentive plan is material to investors as it affects equity compensation structures and potential dilution.
View raw filing on EDGAR →The disclosure centers on stockholder approval of an Amendment and Restatement of the VeriSign 2006 Equity Incentive Plan, which is a compensatory arrangement affecting officers and directors. While the amendment does not increase share availability, it extends the plan's termination date to 2036 and revises administrative provisions governing equity awards. This is a material disclosure of a plan amendment subject to shareholder approval, fitting the exec_compensation category under Item 5.02(e).
View raw filing on EDGAR →The disclosure centers on a compensatory arrangement for the CEO: a first amendment to his employment agreement extending his term through December 31, 2027, and a grant of 40,000 restricted stock units with vesting conditions tied to successor onboarding or continued employment. While the filing also mentions an employment term extension, the substantive material action is the equity grant and modification of compensation terms, which falls squarely within exec_compensation rather than exec_appointment or exec_departure.
View raw filing on EDGAR →The disclosure reports stockholder approval of the Alexander's, Inc. 2026 Omnibus Stock Plan, a broad-based incentive compensation plan providing for stock options, RSUs, performance shares, and other equity awards to executives, officers, and directors. This is a compensatory arrangement disclosure under Item 5.02(e), distinct from executive departures or appointments. The plan's material terms—500,000 shares authorized, replacement of the 2016 Plan, and flexibility in award types—directly affect executive and director compensation structure and would materially inform investor assessment of the company's compensation practices.
View raw filing on EDGAR →The filing discloses a material change to Joseph Visconti's employment arrangement: non-renewal of his formal Employment Agreement effective July 23, 2026, with transition to at-will employment thereafter. While styled as a "non-renewal," this constitutes a significant modification of his compensatory and employment terms as CEO, CFO, and President. The shift from a defined-term agreement to at-will status materially alters his job security and compensation protections, making this a compensatory arrangement disclosure under Item 5.02(e).
View raw filing on EDGAR →The disclosure centers on a First Amendment to Michael Mazzei's employment agreement as CEO, extending his term to March 31, 2030 and modifying his compensatory arrangements—specifically reducing his Annual Cash Bonus and Annual LTIP Award targets for 2027–2029. This is a material modification of executive compensation terms, not a departure or appointment, making exec_compensation the appropriate classification.
View raw filing on EDGAR →The disclosure centers on shareholder approval of an amendment to the 2022 Long-Term Incentive Plan that increased the share pool available for awards by 395,000 shares. This is a compensatory arrangement amendment affecting equity awards for officers and directors, which is the hallmark of Item 5.02(e) compensation disclosures. The materiality stems from the expansion of the equity pool available for future executive compensation.
View raw filing on EDGAR →The filing discloses compensatory arrangements for three named executives: Jason Maddox (President and Interim CFO), Elgin Tracy (COO), and Phillip W. Oldridge (CEO). The arrangements include annual base compensation ($500,000 for Maddox and Tracy; $500,000 for Oldridge), guaranteed car allowances ($2,000/month for 36 months), severance provisions (24 months base plus one year lump sum), change-of-control equity grants (1.5M shares each), and recognition bonuses ($500,000 each for Maddox and Tracy in 2026-2027; $125,000 for Oldridge). These are material compensatory arrangements that would affect investor assessment of executive cost structure and incentive alignment.
View raw filing on EDGAR →This disclosure reports stockholder approval of an amended and restated equity incentive plan reserving approximately 42.9 million shares for issuance under stock options and other equity awards. This is a compensatory arrangement affecting named executives and directors, and the material increase in share reserve and plan amendments constitute a significant change to executive compensation structure that would affect investor assessment of dilution and executive incentives.
View raw filing on EDGAR →The disclosure centers on stockholder approval of Amendment No. 2 to the 2022 Long-Term Incentive Plan, which increases authorized shares for issuance by 2,000,000 shares and expands per-person award limitations to all Eligible Persons including Board members. This is a compensatory arrangement amendment affecting equity awards available to executives and directors, fitting the exec_compensation category. The material increase in share authorization and expanded eligibility make this material to investors assessing the company's equity structure and executive compensation capacity.
View raw filing on EDGAR →The disclosure centers on stock option awards granted to two named executives: Paul DiPerna (Chairman, President, CFO, Treasurer) received 11,218 options and Kevin Schmid (COO) received 4,674 options, with specified exercise price ($3.46), vesting schedule (one-third on May 14, 2027, then monthly thereafter), and 10-year expiration. This is a classic compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure.
View raw filing on EDGAR →The filing discloses stockholder approval of the 2026 Incentive Plan and an amendment and restatement of the Stock Purchase and Deferral Plan at AT&T's Annual Meeting on May 14, 2026. These are compensatory arrangements for officers and employees, directly falling under Item 5.02(e) disclosure requirements. The approval of new equity incentive plans and deferral plan amendments are material compensation governance events affecting executive and employee compensation structures.
View raw filing on EDGAR →The disclosure centers on shareholder approval of amendments to the Alkermes plc 2018 Stock Option and Incentive Plan, increasing authorized shares by 5,900,000 for equity compensation purposes. This is a compensatory arrangement amendment requiring shareholder approval, fitting the exec_compensation category. The material increase in share authorization directly affects the pool available for executive and employee equity grants.
View raw filing on EDGAR →The disclosure centers on shareholder approval of the First Amendment to the 2020 Equity Incentive Plan, which increases the share pool by 3,000,000 shares and extends the plan term to 2036. This is a material compensatory arrangement amendment affecting equity grants available to officers and directors, disclosed under Item 5.02(e) and approved at the May 14, 2026 Annual Meeting of Shareholders.
View raw filing on EDGAR →The disclosure centers on an amendment to the 2019 Equity Incentive Plan that increases available shares for issuance by 500,000 shares (from 700,000 to 1,200,000), which is a material compensatory arrangement affecting equity grants to officers and directors. This is a classic Item 5.02(e) disclosure of a compensation plan amendment approved by shareholders.
View raw filing on EDGAR →The filing discloses Amendment No. 3 to the Executive Employment Agreement with CEO Brandon Torres Declet, modifying Section 2.6 to establish a new deal completion bonus structure contingent on an IPO, direct listing, or Change in Control. This is a compensatory arrangement modification for a named executive officer, fitting the exec_compensation category. The bonus structure (up to 1.5% of net proceeds or $225,000 minimum) is material to investor assessment of executive incentives and potential dilution in a liquidity event.
View raw filing on EDGAR →The disclosure centers on stockholder approval of an amendment to the 2025 Stock Option and Incentive Plan that increases the share pool available for issuance by 900,000 Common Shares. This is a compensatory arrangement amendment affecting equity grants to officers and directors, which falls squarely within exec_compensation. The materiality is supported by the substantial increase in authorized shares for equity compensation purposes.
View raw filing on EDGAR →The filing discloses shareholder approval of the 2026 Long-Term Incentive Plan, which authorizes awards of incentive stock options, nonqualified stock options, stock appreciation rights, performance restricted shares, restricted stock awards, and stock awards to officers, directors, and key employees. This is a compensatory arrangement disclosure under Item 5.02(e), material because it establishes the framework for executive and director compensation going forward.
View raw filing on EDGAR →The disclosure reports shareholder approval on May 20, 2026 of an amendment and restatement of the 2006 Stock Incentive Plan, increasing authorized shares by 300,000 to 2,640,278 shares. This is a compensatory arrangement amendment affecting stock-based awards to directors, officers, and employees, fitting the exec_compensation category. The increase in authorized shares is material to investors assessing dilution and equity compensation capacity.
View raw filing on EDGAR →The filing discloses stockholder approval of amendments to two equity compensation plans: the 2018 Equity Incentive Plan (adding 500,000 shares) and the 2000 Employee Stock Purchase Plan (adding 360,000 shares). These amendments directly affect the compensatory arrangements available to directors and officers under the Company's equity plans, which is the core subject matter of Item 5.02(e). The material increase in authorized shares for equity issuance would affect investor assessment of potential dilution and executive compensation capacity.
View raw filing on EDGAR →The disclosure centers on stockholder approval of the Second Amendment to the Insperity Incentive Plan, which increased the share reserve by 1,620,000 shares available for awards to employees, executive officers, and non-employee directors. This is a compensatory arrangement amendment affecting equity grant capacity for named executives and directors, fitting the exec_compensation category. The materiality is high given the substantial share increase and broad applicability to executive compensation.
View raw filing on EDGAR →The disclosure centers on stockholder approval of an Amended and Restated 2022 Omnibus Incentive Plan that increases the share reserve by 2,000,000 shares. This is a compensatory arrangement affecting equity grants and incentive awards available to officers and directors. While Item 5.02 covers multiple event types, the substantive disclosure here is the plan amendment and shareholder approval of compensation arrangements, not an executive departure or appointment.
View raw filing on EDGAR →The disclosure centers on shareholder approval of Amendment No. 1 to the Team, Inc. 2018 Equity Incentive Plan, which increases the share pool available for equity grants by 250,000 shares. This is a compensatory arrangement amendment affecting the framework for director and officer equity compensation, fitting the exec_compensation category. The event is material as it expands the equity compensation capacity and was subject to shareholder vote approval.
View raw filing on EDGAR →The disclosure centers on shareholder approval of the First Amendment to the 2023 Long Term Incentive Plan, which increases the maximum shares issuable under the equity compensation plan from 71.7 million to 101.7 million Class A shares. This is a material compensatory arrangement amendment affecting the pool of equity available for executive and employee compensation, falling squarely within exec_compensation rather than shareholder_vote_results, as the substance is the compensation plan modification itself.
View raw filing on EDGAR →The disclosure centers on stockholder approval of an amended and restated incentive award plan with a material increase in the aggregate share limit from approximately 12.62 million to 14.32 million shares. This is a compensatory arrangement amendment affecting the pool of equity available for executive and employee awards, which is a core exec_compensation event under Item 5.02(e).
View raw filing on EDGAR →The disclosure centers on stockholder approval of Amendment No. 1 to the 2019 Employee Stock Purchase Plan (ESPP), which increases authorized shares for issuance under the plan from 100,000 to 200,000 shares. This is a compensatory arrangement amendment affecting equity grants available to employees, fitting the exec_compensation category. While the Item 5.02 header mentions multiple topics, the substantive disclosure here is the ESPP plan amendment and its shareholder approval, which is material to investors assessing the company's equity dilution and employee compensation structure.
View raw filing on EDGAR →The filing discloses termination of an Executive Employment Agreement with CEO Darko Horvat, effective retroactively to September 19, 2025, memorialized in a Termination and Release Agreement dated May 13, 2026. While the termination itself might suggest exec_departure, the core disclosure centers on the modification and elimination of compensatory arrangements—the equity grants (stock options, RSUs), annual incentive compensation, and sale bonus—rather than Mr. Horvat's departure from the CEO role (he continues as a non-employee CEO). The material substance is the unwinding of a significant compensation package, making exec_compensation the most precise classification.
View raw filing on EDGAR →The disclosure centers on stockholder approval of an amendment to the 2020 Omnibus Incentive Plan that (i) authorizes an additional 3,650,000 shares for issuance and (ii) increases the maximum aggregate dollar value of equity-based awards and cash compensation for Outside Directors from $350,000 to $750,000. This is a compensatory arrangement disclosure under Item 5.02(e), affecting director compensation limits and equity plan authorization. The materiality is evident from the substantial increase in share authorization and director compensation caps.
View raw filing on EDGAR →The disclosure centers on stockholder approval of amendments to the 2022 Omnibus Equity Award Plan and the 2020 Employee Stock Purchase Plan, increasing share reserves by 2.8 million and 500,000 shares respectively. These are compensatory arrangements affecting equity issuance capacity for officers and employees, fitting the exec_compensation category. The material increase in authorized shares for equity awards makes this material to investors assessing dilution and compensation policy.
View raw filing on EDGAR →The disclosure centers on stockholder approval of an amendment to the AtriCure 2023 Stock Incentive Plan, increasing available shares from 4.5 million to 6 million. This is a compensatory arrangement disclosure under Item 5.02(e), as it involves shareholder approval of a material equity plan amendment that directly affects the compensation vehicles available to directors, officers, and employees. The plan's stated purpose is to provide equity incentives and attract key personnel.
View raw filing on EDGAR →